Conditional Approval for Serum, Bharat Bio COVID-19 Vaccines In India Amid Uproar
Confusion Over Serum's Exports Of AZ Vaccine
India gave a conditional accelerated approval to AstraZeneca partner Serum Institute and separately, to Bharat Biotech for their COVID-19 vaccines. With the latter’s vaccine still in Phase III trials, the unprecedented decision caused a flutter as the regulator had earlier said an EUA would not be granted unless trials are completed.
